Article
The FDA has approved SpermCheck Vasectomy (ContraVac, Inc., Charlottesville, VA), a diagnostic product that confirms men’s post-vasectomy sterility. The device will enable men to test their post-vasectomy fertility status at home, rather than returning to the physician’s office or a laboratory for confirmation.
The FDA has approved SpermCheck Vasectomy (ContraVac, Inc., Charlottesville, VA), a diagnostic product that confirms men’s post-vasectomy sterility. The device will enable men to test their post-vasectomy fertility status at home, rather than returning to the physician’s office or a laboratory for confirmation.
Similar to a home pregnancy test for women, the test has the sensitivity and specificity required to detect low numbers of sperm, according to ContraVac. The test will be available in mid-2008. Physicians will be able to provide the product to their patients who undergo vasectomy, or men can order the product directly from the vendor.
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.